Total Holdings
153
Portfolio diversification across 153 positions
XBI
(NYSEARCA)State Street SPDR S&P Biotech ETF
$152.23-- (--)
Loading... - Market loading
XBI ETF Holdings: State Street SPDR S&P Biotech ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$7.87B
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
State Street
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 49 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Twist Bioscience Corporation | Stock | 2.07% |
| 2 |  | Travere Therapeutics, Inc. | Stock | 2.06% |
| 3 |  | TG Therapeutics, Inc. | Stock | 2.05% |
| 4 |  | Alkermes plc | Stock | 1.81% |
| 5 |  | Revolution Medicines, Inc. | Stock | 1.79% |
| 6 |  | Arrowhead Pharmaceuticals, Inc | Stock | 1.54% |
| 7 |  | Krystal Biotech, Inc. | Stock | 1.45% |
| 8 |  | Beam Therapeutics Inc | Stock | 1.42% |
| 9 |  | Exelixis, Inc. | Stock | 1.42% |
| 10 |  | Nuvalent, Inc. | Stock | 1.41% |
| 11 |  | Neurocrine Biosciences, Inc. | Stock | 1.38% |
| 12 |  | Cytokinetics, Incorporated | Stock | 1.36% |
| 13 |  | Madrigal Pharmaceuticals, Inc | Stock | 1.35% |
| 14 |  | Praxis Precision Medicines, Inc | Stock | 1.34% |
| 15 |  | Veracyte, Inc. | Stock | 1.34% |
| 16 |  | Protagonist Therapeutics, Inc. | Stock | 1.31% |
| 17 |  | Scholar Rock Holding Corp | Stock | 1.30% |
| 18 |  | Apogee Therapeutics, Inc. | Stock | 1.30% |
| 19 |  | Natera, Inc. | Stock | 1.28% |
| 20 |  | Celcuity LLC | Stock | 1.28% |
| 21 |  | CRISPR Therapeutics AG | Stock | 1.28% |
| 22 |  | PTC Therapeutics, Inc. | Stock | 1.27% |
| 23 |  | Mirum Pharmaceuticals, Inc. | Stock | 1.26% |
| 24 |  | Kymera Therapeutics, Inc. | Stock | 1.22% |
| 25 |  | Incyte Corporation | Stock | 1.20% |
| 26 |  | Spyre Therapeutics, Inc. | Stock | 1.20% |
| 27 |  | Halozyme Therapeutics, Inc. | Stock | 1.19% |
| 28 |  | Ionis Pharmaceuticals, Inc | Stock | 1.17% |
| 29 |  | Rhythm Pharmaceuticals, Inc | Stock | 1.17% |
| 30 |  | United Therapeutics Corporation | Stock | 1.17% |
| 31 |  | Biogen Inc | Stock | 1.17% |
| 32 |  | Immunovant Inc | Stock | 1.15% |
| 33 |  | Roivant Sciences Ltd | Stock | 1.14% |
| 34 |  | Summit Therapeutics PLC | Stock | 1.13% |
| 35 |  | AbbVie Inc | Stock | 1.09% |
| 36 |  | BridgeBio Pharma, Inc | Stock | 1.08% |
| 37 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.08% |
| 38 | N NK | NantKwest Inc | Stock | 1.06% |
| 39 |  | Gilead Sciences, Inc | Stock | 1.06% |
| 40 |  | CG Oncology, Inc. Common stock | Stock | 1.03% |
| 41 |  | Vertex Pharmaceuticals Incorporated | Stock | 1.03% |
| 42 |  | GRAIL, LLC | Stock | 1.03% |
| 43 |  | Viking Therapeutics Inc | Stock | 1.02% |
| 44 |  | Amgen Inc | Stock | 1.01% |
| 45 |  | Vaxcyte, Inc | Stock | 1.00% |
| 46 |  | BioMarin Pharmaceutical Inc | Stock | 0.99% |
| 47 |  | ACADIA Pharmaceuticals Inc | Stock | 0.99% |
| 48 |  | Arcutis Biotherapeutics, Inc | Stock | 0.98% |
| 49 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.96% |
Frequently Asked Questions About State Street SPDR S&P Biotech ETF Holdings
What are the top holdings in XBI?
State Street SPDR S&P Biotech ETF (XBI) holds 153 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is XBI's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review XBI's holdings table to analyze concentration risk.
What is XBI's sector allocation?
The Sector Allocation chart shows how XBI distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does XBI invest in?
XBI's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is XBI ETF?
XBI's diversification can be assessed by reviewing its 153 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.